This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.

Browse

Trenbolone

Emerging

Veterinary cattle implant repurposed as the most potent mainstream AAS in bodybuilding.

Aliases (7)
Tren · Trenbolone Acetate · Tren A · Trenbolone Enanthate · Tren E · Finaplix · Revalor
TYPICAL DOSE
Weekly
ROUTE
Intramuscular injection (oil)
Intramuscular
CYCLE
N/A — SKIP-PERMANENT for this profile
Cycle length (8-16 wk)
STORAGE
Room temp; protect from light
Room temp

Overview

What is Trenbolone?

Trenbolone is a potent synthetic anabolic-androgenic steroid (AAS) derived from nandrolone, originally developed for veterinary use to increase cattle muscle growth. It is non-FDA-approved for humans and is used illicitly in bodybuilding for its extreme anabolic effects.

Key Benefits

Produces large gains in lean muscle mass and strength, increases nutrient partitioning toward muscle (glucocorticoid antagonism), reduces body fat, and enhances feed efficiency; effects are stronger per mg than testosterone but with severe side effects (cardiovascular, neuropsychiatric, kidney).

Mechanism of Action

Binds the androgen receptor with very high affinity (3-5x testosterone), driving robust anabolic gene transcription. Trenbolone does not aromatize to estrogen but is a progestin agonist. It also antagonizes glucocorticoid receptors, contributing to anti-catabolic effects, and resists 5-alpha-reductase metabolism, producing a uniformly high androgenic signal.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK
Vial inspection & sterile draw AAS oil

AAS oil arrives pre-suspended in carrier oil — no BAC water needed. Inspect for clarity, color, and crashed compound (cold storage can crystallize). Warm vial in palm or under hot tap before draw.

Steps
  1. 1 Wipe vial stopper with isopropyl alcohol.
  2. 2 Warm vial 30-60s in palm if oil is cold/cloudy.
  3. 3 Draw with 18g needle into 22-25g pin barrel for IM, or 27-29g for sub-Q.
  4. 4 Tap out air bubbles, expel a small drop, then inject at chosen site.
Open dose calculator for Trenbolone
Cycle structure & PCT AAS
Ester
acetate
Frequency
eod
PCT
Required
Phase 1 — On cycle

Ramp dose over week 1, hold steady through cycle weeks. Track baseline labs (TT/FT/E2/SHBG/HCT/lipids/LFTs) at week 0; recheck at week 4 and end-of-cycle.

Phase 2 — Bridge / cease

On the last dose, the ester clears over its half-life window (acetate = est. ~7 days). PCT begins after the active compound has cleared.

Phase 3 — PCT (post-cycle therapy)

Standard PCT is enclomiphene 12.5-25 mg/day or clomid 50/50/25/25 over 4 weeks (or nolvadex 20/20/10/10). HCG bridge optional during cycle to preserve testicular volume + faster restart. Bloodwork at PCT week 4 + 8 to confirm HPG axis recovery (LH, FSH, TT back to baseline).

Research Indications

Most Effective

Androgen receptor (AR) binding affinity ~5× testosterone

among the highest of any AAS. Drives extreme protein synthesis, lipolysis, satellite-cell recruitment.

Effective

Glucocorticoid receptor (GR) agonist

unusual for an AAS. This contributes to lipolysis but also drives cardiovascular damage, anxiety, sleep disruption, and connective-tissue…

Investigational

Progestogenic activity

binds progesterone receptor, can drive prolactin elevation, gynecomastia, sexual dysfunction. Aromatase inhibitors (the standard estrogen…

Investigational

Non-aromatizable

does not convert to estradiol. This sounds advantageous but removes estrogen's cardioprotective role (HDL, vascular endothelium), worseni…

Investigational

5α-reductase resistant

does not convert to DHT, but the parent compound is itself extraordinarily androgenic in tissues.

Peptide Interactions

All AAS
Avoid

stacking compounds the cardiovascular and HPG damage non-linearly.

Stimulants (modafinil, amphetamines, high-dose caffeine)
Avoid

additive cardiovascular load; Tren already raises HR/BP significantly.

SSRIs / antidepressants
Avoid

interacts unpredictably with the AAS-mood axis.

Quality Indicators

White, fluffy cake (peptides)

Lyophilized peptide should appear as a white, fluffy "cake" filling most of the vial bottom. Indicates proper freeze-drying.

Clear solution after reconstitution

After mixing with bacteriostatic water, the solution should be crystal clear with no particles or cloudiness.

!

Slight clumping acceptable

Small clumps that fully dissolve with gentle swirling are normal — shipping can cause minor compaction.

Collapsed or melted powder

Powder that looks collapsed, melted, or stuck to vial sides may have been heat-damaged in transit.

Cloudy or particulate solution

Persistent cloudiness or visible particles after gentle mixing indicate degraded or contaminated material.

What to Expect

  • Week 1-2
    Frontload phase. Strength gains start; appetite up.
  • Week 3-4
    Visible muscle fullness and recovery acceleration.
  • Week 5-8
    Peak performance window. Monitor blood pressure + libido.
  • Post-cycle
    PCT week 1-4. Bloodwork at week 6 post-cycle.

Side Effects & Safety

  • Common (>10% users): Insomnia, night sweats, mood lability, irritability, elevated resting HR, elevated BP, sexual dysfunction (mid-cycle ED), anxiety, decreased cardio capacity, severe HPG suppression (universal).
  • Less common (1-10%): Gynecomastia (progestogenic, not estrogen-mediated — AI does not help, cabergoline may), aggression incidents, panic-attack-like episodes, gross sleep architecture disruption, kidney function decline, hair-loss acceleration in genetically predisposed users, severe acne.
  • Rare-serious (<1% but worth knowing): Acute kidney injury, cardiac event (MI, arrhythmia), psychotic episode, suicidal ideation, persistent post-cycle hypogonadism (failure to recover endogenous T after multiple cycles), tren cough (acute pulmonary reaction during injection — bronchospasm, taste of metal, cough fit lasting minutes; usually self-limited but distressing), rhabdomyolysis.
  • Specific watch periods:
    • Lifetime: brain development is incomplete until ~25; introducing a high-AR + high-GR compound during this window has unstudied long-term consequences for HPA-axis setpoint, mood circuitry, and androgen-receptor sensitization.
    • First 4 weeks: psychiatric side effects (sleep, mood) often peak.
    • Mid-cycle through PCT: sexual dysfunction, lipid damage, kidney/cardiac surveillance.
    • 6-12 months post-cycle: ASIH may persist; some users never fully recover.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Trenbolone

More in AAS · Oil injectable

7 compounds in bucket